A field guide to Aurora kinase inhibitors: an oocyte perspective

Cecilia S Blengini1,2, Gyu Ik Jung1,2, Mansour Aboelenain1,2,3

  • 1Department of Genetics, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.

Reproduction (Cambridge, England)
|September 20, 2022
PubMed

Insights

This study introduces a new assay to measure Aurora kinase activity in oocytes. We found specific inhibitor doses for Aurora kinase A and C, crucial for oocyte maturation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Reproductive Biology

Background:

  • Aurora protein kinases are vital for oocyte meiotic maturation.
  • Small molecule inhibitors targeting Aurora kinases are used in somatic cells.

Purpose of the Study:

  • To develop an assay for assessing Aurora kinase activation in oocytes.
  • To determine optimal doses for commonly used Aurora kinase inhibitors.
  • To evaluate the specificity of these inhibitors in mouse oocytes.

Main Methods:

  • Development of a novel assay to measure Aurora kinase activation state.
  • Testing of three common small molecule inhibitors in mouse oocytes.
  • Dose-response analysis to determine inhibitor specificity.

Main Results:

  • The study established an effective assay for oocyte Aurora kinase activation.
  • MLN 8237 demonstrated specificity for Aurora kinase A at low concentrations.
  • AZD 1152 showed specificity for Aurora kinase C at low concentrations.

Conclusions:

  • Specific low-dose inhibitors can be used to target Aurora kinase A and C in oocytes.
  • These findings are critical for understanding oocyte meiotic regulation.
  • The developed assay provides a tool for future research on Aurora kinases in oocytes.